James Hartley. “Aberrant Splicing Factor SF3A2 As a Prognostic Biomarker and Therapeutic Target in Colorectal Cancer: Interplay With Immune Infiltration and Natural Product Intervention”. International Journal of Medical Science and Dental Health, vol. 12, no. 09, Sept. 2026, pp. 176-81, https://doi.org/10.55640/ijmsdh-12-09-20.